Table 1.
Baseline characteristics of all participants
| N (%) | |
|---|---|
| Age in years Median (Interquartile range) |
45(13) |
| Female | 64(60) |
| Hematemesis | 103 (96) |
| Melena | 47(44) |
| Hematochesia | 55(51) |
| Admitted with severe acute UGIB | 23(22) |
| Prevalence of UGIB among out patients | 84(24) |
| Total Episodes of UGIB reported in the study | 323 |
| Episodes of UGIB reported by each participant Median (Interquartile range) |
2 (3) |
| Previously or currently admitted for UGIB | 103 (96) |
| Ever had an endoscopy for UGIB | 0 |
| Had a blood transfusion for UGIB | 73(68) |
| Certain Hepatic schistosomiasis (Ultrasound patterns D, E, F, X and/ or previous ova of S. mansoni in stool) |
101 (94) |
| Praziquantel last 12 months | 70(65) |
| Alcohol use | 4 (4) |
| Liver flap | 10 (9) |
| Ascites on examination | 18 (17) |
| Palpable spleen | 92 (90) |
| Ascites on ultrasound | 15 (14) |
| Splenomegaly on ultrasound (spleen diameter ≥12cm) | 86 (82) |
| Portal vein diameter ≥1.3cm | 75 (73) |
| Niamey liver ultrasound protocol No or mild periportal fibrosis (pattern A, C,) Moderate or Severe periportal fibrosis (pattern D, E, F) |
9 (8) 59 (55) 39 (37) |
| Collaterals at ultrasound | 5 (5) |
| Hepatitis B surface antigen positive | 7 (7) |
| Hepatitis C antibody positive | 28 (26) |
| Treated with praziquantel in the last 12 months | 70 (78) |
| Schistosoma mansoni ova in stool smear | 7 (7) |
| Positive urine circulating cathodic antigen (CCA) test | 9 (8) |
| Hemoglobin level (g/L) Median (Interquartile range) |
102 (45) |
| Platelet count (x109/L) Median (Interquartile range) |
54 (53) |
| Esophageal varices at endoscopy Portal hypertensive gastropathy Peptic ulcer disease at endoscopy |
86 (80) 83 (78) 18 (17) |
UGIB-upper gastrointestinal bleeding